Show/Hide Menu
Hide/Show Apps
Logout
Türkçe
Türkçe
Search
Search
Login
Login
OpenMETU
OpenMETU
About
About
Open Science Policy
Open Science Policy
Open Access Guideline
Open Access Guideline
Postgraduate Thesis Guideline
Postgraduate Thesis Guideline
Communities & Collections
Communities & Collections
Help
Help
Frequently Asked Questions
Frequently Asked Questions
Guides
Guides
Thesis submission
Thesis submission
MS without thesis term project submission
MS without thesis term project submission
Publication submission with DOI
Publication submission with DOI
Publication submission
Publication submission
Supporting Information
Supporting Information
General Information
General Information
Copyright, Embargo and License
Copyright, Embargo and License
Contact us
Contact us
In vitro susceptibilities of Candida spp. to panomycocin, a novel exo-beta-1,3-glucanase isolated from Pichia anomala NCYC 434
Date
2007-01-01
Author
Izgue, Fatih
Altinbay, Demet
Tuereli, Akif Emre
Metadata
Show full item record
This work is licensed under a
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
.
Item Usage Stats
35
views
0
downloads
Cite This
Panomycocin, the killer toxin of Pichia anomala NCYC 434 (K5), is a 49 kDa monomeric glycoprotein with exo-beta-1,3-glucanase activity (patent pending). In this study we evaluated the in vitro activity of panomycocin against a panel of 109 human isolates of seven different pathogenic Candida spp. using microdilution and time-kill methods. Panomycocin was most active against C. tropicalis, C. pseudotropicalis and C. glabrata with MIC90 values of 1 mu g/ml. It displayed significant activity against C. albicans and C. parapsilosis with MIC90 values of 4 and 2 mu g/ml, respectively. For C. krusei, the MIC90 value was 8 mu g/ml. Panomycocin was fungicidal against all the tested Candida spp. The MFC values were only one or 2 dilutions higher than the MICs with the exception of C. krusei isolates with MFCs greater than or equal to 4 X MIC. Results of this study indicated that panomycocin could be considered as a natural antifungal agent against Candida infections and has significant potential for further investigation.
Subject Keywords
Immunology
,
Microbiology
,
Virology
,
Yeast killer toxin
,
Exo-beta-1,3-glucanase
,
Susceptibility testing
,
Candida species
URI
https://hdl.handle.net/11511/66753
Journal
MICROBIOLOGY AND IMMUNOLOGY
DOI
https://doi.org/10.1111/j.1348-0421.2007.tb03975.x
Collections
Department of Biology, Article
Suggestions
OpenMETU
Core
The effect of sustained and local administration of epidermal growth factor on improving bilateral testicular tissue after torsion
Uguralp, S; Karabulut, AB; Mizrak, B; Kaymaz, F; Kiziltay, A; Hasırcı, Nesrin (2004-10-01)
Epidermal growth factor (EGF) modulates Leydig cell proliferation, steroidogenesis, spermiogenesis, and Sertoli cell activity. It plays an important role in repairing ischemia-reperfusion injury in different tissues. The aim of this study was to evaluate the effects of sustained and local administration of EGF on improving bilateral testicular tissue after torsion. A total of 57 Wistar albino rats were used. For the EGF transport system, 1x2 cm gelatin films containing 2 mug EGF were used. Torsion was creat...
In vitro activity of panomycocin, a novel exo-beta-1,3-glucanase isolated from Pichia anomala NCYC 434, against dermatophytes
Izgu, Fatih; Altinbay, Demet; Tureli, Akif Emre (2007-01-01)
Killer proteins that are produced and secreted into the environment by certain yeast strains are considered as promising antifungal agents. In this study, in vitro activity of Pichia anomala NCYC 434 (K5) killer protein, panomycocin, which is a 49 kDa glycoprotein with an exo-beta-1,3-glucanase activity was tested against 41 isolates of dermatophytes. Minimum inhibitory concentrations (MICs) were determined by a broth microdilution method based on the reference document M38-A of Clinical and Laboratory Stan...
In vitro evaluation of zoledronic acid resistance developed in MCF-7 cells
Kars, Meltem Demirel; Iseri, Ozlem Darcansoy; Ural, Ali Ugur; Gündüz, Ufuk (2007-11-01)
Background: Zoledronic acid is an important osteotropic compound used in combination with anticancer agents to reduce the incidence of hypercalcemia and skeletal morbidity in patients with advanced breast cancer and bone metastases. Ineffectiveness of anticancer drugs during chemotherapy is a frequently observed situation in cancer chemotherapy. The resistance of tumor cells to more than one cytotoxic drugs is defined as multidrug resistance. Drug resistance may be caused by altered gene expression levels a...
An efficient synthesis of (1S, 2R)-1-amino-2-indanol, a key intermediate of HIV protease inhibitor, indinavir
Demir, Ayhan Sıtkı; Aksoy-Cam, H; Camkerten, N; Hamamcı, Haluk; Doganel, F (2000-01-01)
(1S,2R)-1-amino-2-indanol, a key component of an HIV protease inhibitor is synthesized in four steps starting from indanone. The Mn(OAC)(3) mediated acetoxylation of indanone followed by fungus catalyzed hydrolysis of acetoxyindanone furnished optically pure alpha-hydroxy indanone. Formation and enantioselective reduction of oxime ether of 2-hydroxyindanone afforded (1S, 2R)-1-amino-2-indanol in 97% cis selectivity.
Some endohedrally beryllium doped C-116 structures - PM3 treatment
Türker, Burhan Lemi (2002-07-26)
Endohedrally Be species doped C-116, the strong dimer of C-60, structures are considered for PM3 (RHF) type semiempirical quantum chemical treatment. The structures were found to be stable but endothermic. However, Be@C-116 was found to be more stable and less endothermic than C-116 and Be-2@C-116 even found to be more stable and less endothermic than the others. The probable causes for this behavior are discussed.
Citation Formats
IEEE
ACM
APA
CHICAGO
MLA
BibTeX
F. Izgue, D. Altinbay, and A. E. Tuereli, “In vitro susceptibilities of Candida spp. to panomycocin, a novel exo-beta-1,3-glucanase isolated from Pichia anomala NCYC 434,”
MICROBIOLOGY AND IMMUNOLOGY
, pp. 797–803, 2007, Accessed: 00, 2020. [Online]. Available: https://hdl.handle.net/11511/66753.